IRBESARTAN RANBAXY irbesartan 150 mg tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
28-11-2017

Toimeaine:

irbesartan, Quantity: 150 mg

Saadav alates:

Sun Pharma ANZ Pty Ltd

INN (Rahvusvaheline Nimetus):

Irbesartan

Ravimvorm:

Tablet, film coated

Koostis:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; croscarmellose sodium; hypromellose; colloidal anhydrous silica; titanium dioxide; macrogol 4000

Manustamisviis:

Oral

Ühikuid pakis:

30, 90

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

- Indicated for the treatment of hypertension.,- Indicated for delaying the progression of renal disease in hypertensive type II diabetics with persistent micro-albuminuria (greater than or equal to 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Toote kokkuvõte:

Visual Identification: White to off-white, film-coated, oval-shaped, biconvex tablet debossed with 'I4' on one side and plain on the other.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Volitamisolek:

Registered

Loa andmise kuupäev:

2012-09-17